By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Peregrine Pharmaceuticals, Inc. 

14272 Franklin Avenue
Suite 100
Tustin  California  92780  U.S.A.
Phone: 714-508-6000 Fax: 714-838-5817


SEARCH JOBS




Collaborations

AVANIR 





Company News
Peregrine (PPHM) Reports Financial Results For First Quarter Of Fiscal Year 2018 And Recent Developments 9/12/2017 11:24:10 AM
Peregrine (PPHM) Announces Appointment Of Roger J. Lias, Ph.D. As President Of Avid Bioservices, Inc. 9/11/2017 10:39:56 AM
Peregrine (PPHM) To Report Financial Results For First Quarter Of Fiscal Year 2018 After Market Close On September 11, 2017 9/7/2017 10:58:29 AM
Peregrine (PPHM) Announces First Patient Dosed In Phase II Clinical Trial Evaluating Bavituximab Treatment Combination In Patients With Newly Diagnosed Glioblastoma 9/7/2017 10:19:24 AM
Peregrine (PPHM) Declares Quarterly Dividend On Its Series E Convertible Preferred Stock 9/6/2017 10:53:13 AM
Peregrine (PPHM) Slashes Workforce by 20% in Cost Cutting Plan 8/11/2017 7:36:11 AM
Peregrine (PPHM) Provides Strategic Update 7/31/2017 1:04:30 PM
Peregrine (PPHM) Issues Statement Regarding Ronin Trading And SW Investment Management’s Letter To Stockholders 7/14/2017 10:42:26 AM
Peregrine (PPHM) Declares Quarterly Dividend On Its Series E Convertible Preferred Stock 6/7/2017 10:20:45 AM
Peregrine (PPHM) Presents Preliminary Correlative Analysis Of PD-L1 Expression From SUNRISE Trial At ASCO 2017 6/5/2017 11:59:22 AM
12345678910...
//-->